Latest News
“Pocket Press” for Cardiac Implantable Electronic Devices
“Pocket Press” for Cardiac Implantable Electronic Devices
August 10th, 2023
RSK Medical has begun distribution of the “Pocket Press” for Cardiac Implantable Electronic Devices (CIED*) across Canada. This new modern pressure bandage is manufactured by Compress Innovations after significant experience in the wound and implantable cardiac rhythm devices industry. With significant CRM experience in the industry, we look forward to standardizing and improving the pressure dressing over devices to reduce the incidence of hematomas in this large group of patients.
The Pocket Press is pre-assembled with a standardized level of compression utilizing a 3-anchor design and a high density foam to maximize compression over the pocket. Please view the Virtual In-service video at the website: www.pressuredressings.com. We are pleased to provide a means of reducing the number of hematomas and therefore the further risk of infections in device patients.
TricValve® – Transcatheter Bicaval Valves System
TricValve® – Transcatheter Bicaval Valves System
April 13, 2023
We are very pleased to announce a distribution agreement across Canada for the P&F TRICVALVE TRANSCATHETER BICAVAL VALVES system. It is designed for the treatment of severe and symptomatic Tricuspid Regurgitation. The system consists of two self-expanding valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. The bioprostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. It is especially intended for use for patients who are not candidates for open surgical therapy.
The system does not yet have regulatory approval in Canada. The TRICVALVE system is approved for use in Europe (CE Mark) with now over 1,000 implants worldwide.
electroCore non-invasive Vagal Nerve Stimulator
electroCore non-invasive Vagal Nerve Stimulator
February 1st, 2023
Pulmonary Valve Replacement-VENUS-MEDTECH agreement
Pulmonary Valve Replacement-VENUS-MEDTECH agreement
November 7th, 2022
RSK Medical Inc. is pleased to announce a partnership with TOZUDA Inc. to distribute their HEAD IMPACT SENSOR across Canada.
RSK Medical Inc. is pleased to announce a partnership with TOZUDA Inc. to distribute their HEAD IMPACT SENSOR across Canada.
May 26th, 2022
“TOZUDA came to my attention on LinkedIn as I have suffered a few concussions myself while playing football, hockey and downhill skiing in my past, said President, Scott Kadwell of RSK Medical Inc.. “I was also touched by the movie called “Concussion” depicting the findings of pathologist Dr. Bennett Omahu who brought the issue of brain damage to the forefront amongst NFL football players and the public domain. He discovered “Chronic Traumatic Encephalopathy” (CTE) in Pittsburgh Steeler players who had experienced repeated head blows which had terrible effects on their medical conditions and lifespan.
“It is easy for parents or coaches to assume players will not incur head injuries and some associations are afraid to acknowledge even the best protocols will not pick up all the head injuries due to the nature of the support and how hits impact people differently”. “Intentional or accidental hits are going to happen”. “It is important to have the “peace of mind” that the high impact hits will get checked out”. It is scientifically documented that 50% of head injuries go under diagnosed or undetected. In addition, 90% of diagnosed head injuries do not involve a loss of consciousness. Each additional hit is accumulative to causing further damage to the injured brain.
The TOZUDA Head Impact Sensor can be easily attached to hockey, snowboarding, snow-skiing, football, cycling and construction helmets to name a few. Please check out the www.tozuda.com website for further information or contact RSK Medical Inc. at generalinquiry@rskmedical.com
Please take note we also represent electroCore which manufactures a non-invasive Vagus Nerve Stimulator (nVNS) called the Sapphire for treatment of migraine and cluster headaches.
RSK Medical Inc. is pleased to announce a nationwide distribution agreement with Texray AB
RSK Medical Inc. is pleased to announce a nationwide distribution agreement with Texray AB
April 28th, 2022
RSK Medical Inc. is pleased to announce a nationwide distribution agreement with Texray AB located in Kungsbacka, Sweden effective immediately.
Texray has invented the only radiation protection textile in the world. Their unique material and product design can reduce scatter radiation towards the head and neck by up to 97% to enhance the safety of healthcare professionals.
The Texray product line can be used in interventional electrophysiology, cardiology, radiology and endovascular surgery procedures where RSK Medical already offers other specialty products.
We look forward to introducing the Texray radiation protection products across Canada.
Read more at the Texray web site.
First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
August 20th, 2021
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360®Coronary Orbital Atherectomy System (OAS).
The first patients in Canada were treated by Sanjog Kalra, MD, Interventional Cardiologist and Cardiac Critical Care Physician at the Peter Munk Cardiac Centre, Toronto General Hospital, part of the University Health Network.
RSK Medical Inc. signs agreement with Cardiovascular Systems, Inc.
RSK Medical Inc. signs agreement with Cardiovascular Systems, Inc.
April 30, 2021
RSK Medical Inc. and Cardiovascular Systems Inc.(CSI), manufacturers of the proven Diamondback 360 orbital rotational atherectomy systems for peripheral and coronary use have signed an agent representation agreement for sales, marketing and clinical support across Canada. The Diamondback 360 offers a low profile (6Fr compatible) system for the radial or femoral approach. The system has a unique mechanism of action (MOA) using a combination of centrifugal force and differential sanding to safely and simply reduce arterial calcium to enable successful stent delivery. The two platforms have been fully approved by Health Canada and we look forward to launching Diamondback 360 over the next few months. Please see www.csi360.com for further product details and clinical data.
New Distribution Agreement with Angiodroid, manufacturer of the CO2 Injector
New Distribution Agreement with Angiodroid, manufacturer of the CO2 Injector
March 24, 2021
RSK Medical Inc. has signed a long term agreement (Canada-wide) to represent Angiodroid Srl from Bologna, Italy.
Angiodroid manufacturers The CO2 Injector, the first system for Automated Carbon Dioxide Angiography (ACDA) dedicated to diagnostic and interventional procedures in peripheral and venous systems.
The Safety and Efficacy of Angiodroid’s CO2 injector has been validated in over 20 international clinical studies to date. This technology makes it possible to use CO2, a 100% biocompatible gas to obtain high quality radiological angiographic images while preserving the renal function of the patients. The ACDA system system avoids all contrast induced nephropathy risks and potential for allergic reactions.
Angiodroid has begun preparation for submitting for Health Canada regulatory approval. Find more on www.angiodroid.com.
Prytime Medical Health Canada approval for New ER-REBOA PLUS Catheter
Prytime Medical Health Canada approval for New ER-REBOA PLUS Catheter
November 17, 2020
Prytime Medical Devices, Inc. introduced its latest aortic occlusion catheter. The ER-REBOA PLUS catheter is designed for improved ease of use, now guide wire-compatible (up to .025 “) with improved depth markings for insertion without imaging.
“The original ER-REBOATM catheter was an important start in delivering a new technology to help clinicians stabilize and manage certain scenarios of bleeding and shock; a technology that, to date, has contributed to saving hundreds of lives,” said Col. (Dr.) Todd Rasmussen, Director of the Battlefield Shock and Resuscitation Research Program at the Uniformed Services University of the Health Sciences. “However, we recognized from the outset that the original design and device would evolve. Even iterative changes in the technology, such as with the ER-REBOATM PLUS, stand to make the devices easier to use, safer and more effective.“
Distribution agreement with NeoChord Inc.
Distribution agreement with NeoChord Inc.
September 08, 2020
COVID-19 Statement
COVID-19 Statement
May 02, 2020
RSK Medical Inc. and its many suppliers would like to thank all the medical care providers and essential workers for their heroic efforts during the current COVID-10 pandemic. The great commitment and continued support will not be forgotten.
